Comment: The central justification for aspirin use in primary prevention has long relied on the “Legacy Effect”—the theory that years of early exposure act as a biological investment, paying dividends in reduced cancer risk decades later. This follow-up to the ASPREE trial effectively demolishes that hypothesis for older adults. We are witnessing a stark collision […]
Comment: The clinical management of advanced melanoma has been transformed by the arrival of anti-PD-1 immunotherapy, yet we frequently observe a frustrating divergence in response among patients receiving the same conventional standard-of-care. This observational cohort study of 200 patients identifies a critical metabolic requirement that likely dictates the success of these conventional treatments: serum vitamin […]
Comment: Although conventional treatments for breast cancer has made astounding improvements over the 35 years that I’ve been in the field, we have to acknowledge that along with it comes a long-term price paid by the patient’s systemic health. This study provides a definitive signal on the iatrogenic risks associated with the standard-of-care. The clinical […]
Comment: This synthesis of 80 meta-analyses corrects the long-standing bias that favors high-intensity aerobic training over more accessible, multi-systemic interventions. While aerobic fitness remains a vital component of recovery, this review highlights that Tai Chi and Qigong are clinically efficacious for preserving functional independence and psychological resilience. These modalities offer high-value interventions for addressing treatment-related […]
Comment: A central issue in palliative oncology is the historical focus on aggressive salvage therapies that frequently lead to negative impacts on QOL rather than measurable survival gains. Metronomic capecitabine reverses this risk-benefit calculation, delivering a median overall survival of 18 months in responders while reporting no treatment-related deaths or severe toxicities. In a population […]
Comment: The primary disconnect in this data is the dramatic, nearly five-fold reduction in local-regional recurrence that fails to translate into a statistically significant overall survival benefit for the general cohort. While a 10-year local recurrence rate of 11% compared to 22% is a clear victory for regional management, the P=.063 for overall survival reminds […]
Comment: This synthesis serves as a robust rebuttal to the long-standing “precautions” that have dominated lymphedema education. The findings demonstrate that most traditional prohibitions—specifically air travel and blood pressure measurements—are effectively myths that lack Level 1 or 2 evidence. The core tension is between a historical focus with these external triggers and the clinical reality […]
Comment: While the biomarker shifts and preclinical toxicity reductions in this review are biologically profound, it is always important to remember that mechanistic success rarely translates directly to human clinical outcomes. That being clear, on a risk-benefit assessment, there is no reason to not include genistein, and some clear signals to. The tangible significance of […]
Comment: This pilot study offers a compelling glimpse into how targeting the tumor microenvironment (TME) through unconventional mechanisms can yield profound biological results. By utilizing a low-dose, pro-oxidant combination of Resveratrol and Copper, researchers were able to essentially “neutralize” the TME by deactivating cell-free chromatin particles. The downstream biochemical effects were remarkable: a highly significant […]
Comment: This study provides the critical ‘why’ behind the findings from this same groups earlier study. In that article, we highlighted that exogenous thyroid hormone is associated with significantly shortened survival in SR+ breast cancer patients. Now, this research explains elucidates the underlying mechanism: thyroid hormone essentially ‘hijacks’ the estrogen receptor, driving proliferation and rendering […]
